AIMS: To study the systematic assessment of need for care and clinical parameters for use in treatment plans in patients diagnosed with severe mental illness. METHODS: The Cumulative Needs for Care Monitor (CNCM) includes various validated instruments, such as the Camberwell Assessment of Need. A Markov-type cost-effectiveness model (health care perspective, 5-year time horizon) was used to compare CNCM with care as usual (CAU). Two studies were used to determine model parameters: a before–after study (n = 2155) and a matched-control study (n = 937). RESULTS: The CNCM may lead to a gain in psychiatric functioning according to the models. CNCM patients remain in (outpatient) care, while CAU patients drop out more frequently. There is only a small difference in inpatient care. As a result, average costs per patient in the CNCM group are between €2809 (before–after model) and €5251 (matched-control model) higher. The iCER was between €45 127 and €57 839 per life year without psychiatric dysfunction gained. CONCLUSIONS: CNCM may be only cost-effective when willingness to pay for a life year without psychiatric dysfunction is higher than €45 000. However, this result is highly sensitive to the level of psychiatric dysfunctioning in patients who do not receive care.
AIMS: To study the systematic assessment of need for care and clinical parameters for use in treatment plans in patients diagnosed with severe mental illness. METHODS: The Cumulative Needs for Care Monitor (CNCM) includes various validated instruments, such as the Camberwell Assessment of Need. A Markov-type cost-effectiveness model (health care perspective, 5-year time horizon) was used to compare CNCM with care as usual (CAU). Two studies were used to determine model parameters: a before–after study (n = 2155) and a matched-control study (n = 937). RESULTS: The CNCM may lead to a gain in psychiatric functioning according to the models. CNCM patients remain in (outpatient) care, while CAU patients drop out more frequently. There is only a small difference in inpatient care. As a result, average costs per patient in the CNCM group are between €2809 (before–after model) and €5251 (matched-control model) higher. The iCER was between €45 127 and €57 839 per life year without psychiatric dysfunction gained. CONCLUSIONS: CNCM may be only cost-effective when willingness to pay for a life year without psychiatric dysfunction is higher than €45 000. However, this result is highly sensitive to the level of psychiatric dysfunctioning in patients who do not receive care.
Authors: P H Robert; E Michel; J Van Os; A C Altamura; J Bobes; J Gerlach; J S E Hellewell; S Kasper; D Nabel Journal: Encephale Date: 2007 Jan-Feb Impact factor: 1.291
Authors: Stefan Priebe; Rosemarie McCabe; Jens Bullenkamp; Lars Hansson; Christoph Lauber; Rafael Martinez-Leal; Wulf Rössler; Hans Salize; Bengt Svensson; Francisco Torres-Gonzales; Rob van den Brink; Durk Wiersma; Donna J Wright Journal: Br J Psychiatry Date: 2007-11 Impact factor: 9.319
Authors: Marjan Drukker; Jim van Os; Miriam Dietvorst; Sjoerd Sytema; Ger Driessen; Philippe Delespaul Journal: BMC Psychiatry Date: 2011-03-21 Impact factor: 3.630
Authors: Jeffrey M Pyne; Kathryn M Rost; Mingliang Zhang; D Keith Williams; Jeffrey Smith; John Fortney Journal: J Gen Intern Med Date: 2003-06 Impact factor: 5.128
Authors: Mario Maj; Jim van Os; Marc De Hert; Wolfgang Gaebel; Silvana Galderisi; Michael F Green; Sinan Guloksuz; Philip D Harvey; Peter B Jones; Dolores Malaspina; Patrick McGorry; Jouko Miettunen; Robin M Murray; Keith H Nuechterlein; Victor Peralta; Graham Thornicroft; Ruud van Winkel; Joseph Ventura Journal: World Psychiatry Date: 2021-02 Impact factor: 49.548